VIATRIS INC. Multiemployer Plans, Withdrawal Obligation
VIATRIS INC. (VTRS) had Multiemployer Plans, Withdrawal Obligation of $5.50 million as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits
us-gaap:MultiemployerPlansWithdrawalObligation · last filed 2022-02-28
- 2021-12-31: Multiemployer Plans, Withdrawal Obligation $5.50M.
- 2020-12-31: Multiemployer Plans, Withdrawal Obligation $8.90M.
- 2019-12-31: Multiemployer Plans, Withdrawal Obligation $12.10M.
- 2016-12-31: Multiemployer Plans, Withdrawal Obligation $27.30M.
| Period end | Multiemployer Plans, Withdrawal Obligation |
|---|---|
| 2021-12-31 | $5.50M 10-K · filed 2022-02-28 |
| 2020-12-31 | $8.90M 10-K · filed 2022-02-28 |
| 2019-12-31 | $12.10M 10-K · filed 2021-03-01 |
| 2016-12-31 | $27.30M 10-K · filed 2022-02-28 |
| 2015-12-31 | $27.30M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |